A comparison of the EQ-5D and SF-6D across seven patient groups.
By J. Brazier, Jennifer Roberts, A. Tsuchiya, J. Busschbach. Health Economics, 2004
834 citations recorded by the source corpus.
Subfields: Economics and Econometrics
View Paper: https://www.semanticscholar.org/paper/824c60debf93835afd1ade2e55664444d477841d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Matthijs M. Versteegh
- Karin M Vermeulen
- Silvia M A A Evers
- bullet A Simon Pickard
- G. de Wit
- bullet Dominik
- R. Prenger
- L. Scalone
Citations in the corpus
- Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus (2009, positive): “Two recent studies using shorter forms of this instrument (127,128) reported a significant reduction of overall self-perceived levels of well-being in LUMINA patients (129), or a reduction in physical function score in the Carolina Lupus Study patients compared with a general population comparison g”
- Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study (2012, background): “Moreover, several studies reported a ceiling effect of the 3L in both general population and patient settings [13–18].”
- Dutch Tariff for the Five-Level Version of EQ-5D. (2016, background): “[3] Brazier JE, Roberts J, Tsuchiya A, Busschbach J.”